According to Telesis Bio's latest financial reports the company has $19.15 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $43.57 M | -47.37% |
2021-12-31 | $82.8 M | 515.06% |
2020-12-31 | $13.46 M | -53.81% |
2019-12-31 | $29.14 M |